Comparison of male breast cancer in China and the US: a real-world cohort study [0.03%]
中国和美国男性乳腺癌的比较：一项真实世界队列研究
Yuxuan Gao,Mengmeng Zhang,Jianyun Nie et al.
Yuxuan Gao et al.
Background: Male breast cancer (MBC) is a rare disease. Limited studies have investigated Chinese MBC patients or compared them with patients in other countries. This study aims to explore the features of Chinese MBC pati...
Axillary management in patients with sentinel lymph node micrometastases following neoadjuvant systemic therapy: a call for de-escalation [0.03%]
新辅助系统治疗后腋窝淋巴结微转移患者的腋窝处理：降低治疗强度的呼吁
Muharrem Oner,Kefah Mokbel
Muharrem Oner
Combined treatment of inetetamab plus pyrotinib and vinorelbine in managing advanced HER2-positive breast cancer patients (ILLUMINE): a multicenter, retrospective, real-world study [0.03%]
伊宁妥联合吡咯替尼和长春瑞滨治疗晚期HER2阳性乳腺癌的疗效及安全性：一项真实世界回顾性研究(Illumine)
Nan Jin,Min Tian,Mengyao Zha et al.
Nan Jin et al.
Background: Breast cancer is the most common tumor among women worldwide, which human epidermal growth factor receptor 2 (HER2)-positive subtype accounts for approximately 15-20%. Although anti-HER2 agents have already di...
TARGIT-IORT in early breast cancer-real world evidence for a risk-adapted approach [0.03%]
早期乳腺癌TARGIT-IORT真实世界证据的个体化风险评估和治疗研究
Hans-Christian Kolberg
Hans-Christian Kolberg
Methodological considerations in predicting axillary residual disease using imaging features [0.03%]
影像学特征预测腋窝残余病灶的方法学考虑因素
Janhavi Venkataraman,Kefah Mokbel
Janhavi Venkataraman
Patient outcomes and clinician perspectives following one year of ad hoc implementation of neoadjuvant endocrine therapy in early breast cancer [0.03%]
新辅助内分泌治疗在早期乳腺癌中的实施效果及临床医生的观点
Sarah Fennelly,Bhaumik Shah,Michael Issac et al.
Sarah Fennelly et al.
Background: Neoadjuvant endocrine therapy (NAET) can induce a reduction of Ki-67 in hormone receptor-positive breast cancer, predicting response to adjuvant endocrine therapy and potentially allowing patients to forego ch...
Organoids in breast cancer translational research: intersection of technologies [0.03%]
类器官在乳腺癌转化研究中的应用：技术交汇点
Qimin Xu,Sangsang Zhu,Meijun Wang et al.
Qimin Xu et al.
Breast cancer has a high incidence and high heterogeneity among women worldwide, but its lack of highly consistent in vitro research models has limited the translation of experimental results into clinical applications. The emergence of tum...
Could circulating tumor cells explain why breast conservation improves survival despite higher locoregional recurrence? [0.03%]
循环肿瘤细胞能解释为什么保乳术改善生存率尽管局部区域复发更高吗？
Muharrem Oner,Kefah Mokbel
Muharrem Oner
The impact and mechanisms of CRIP2 on the biological behavior of triple-negative breast cancer cells [0.03%]
CRIP2对三阴性乳腺癌细胞生物学行为的影响及机制研究
Zhihua Tan,Hongming Chen,Yu Ren et al.
Zhihua Tan et al.
Background: Triple-negative breast cancer (TNBC) is a distinct form of breast cancer that poses a significant threat to patients due to its high invasiveness, high recurrence and metastasis rates, and its lack of clear an...